This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Dipharma Francis S.r.l.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Marco Curzi: Innovator in Antidepressant Compounds
Introduction
Marco Curzi is a notable inventor based in Medicina, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antidepressant compounds. His innovative work has led to the creation of novel crystalline forms that enhance the efficacy of existing medications.
Latest Patents
Marco Curzi holds a patent for "Crystalline forms of an antidepressant compound." This invention relates to novel crystalline forms of vortioxetine hydrobromide, specifically three crystalline forms. The patent also details a process for their preparation, a pharmaceutical composition containing these forms, and a purification process for vortioxetine or its salts.
Career Highlights
Curzi is associated with Dipharma Francis S.r.l., where he applies his expertise in pharmaceutical innovation. His work has been instrumental in advancing the understanding and application of antidepressant compounds in medical treatments.
Collaborations
Marco Curzi collaborates with esteemed colleagues such as Stefano Luca Giaffreda and Elena Dichiarante. Their combined efforts contribute to the ongoing research and development in the pharmaceutical sector.
Conclusion
Marco Curzi's contributions to the field of antidepressant compounds exemplify the impact of innovative thinking in pharmaceuticals. His work continues to influence the development of effective treatments for mental health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile